Abstract
SummaryDecision making in public health often happens against the background of scarce resources. The systematic use of economic evaluations can be a main enabler in the alignment of public health goals with budgetary constraints. However, the lack of standardized methodology in terms of costing method and perspective are a critical barrier to the implementation of economic evaluations and the international comparability of results. We present a novel set of 22 reference unit costs (RUCs) optimized for cross-sectoral economic evaluations in Austria suitable for international comparability calculated using the standardized PECUNIA RUC Template. The common framework for costing and reporting, as well as the easy availability of the RUCs will reduce the burden on researchers and policy makers in future economic evaluations. The higher quality, accuracy, transparency and availability of economic evidence for policy design will help to improve the efficiency of public health-relevant healthcare decisions and make it easier for policy makers to bring funding arrangements and decision making across multiple sectors in line with Health-in-All-Policies goals.
Funder
HORIZON EUROPE Framework Programme
Medical University of Vienna
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. OECD Statistics. Health expenditure and financing: current expenditure on health as share of gross domestic product (1990–2020, Austria). https://stats.oecd.org/. Accessed 22 Mar 2022.
2. Endel G, Lichtenecker J, Knopp A, Koinig H, Nachtnebel A, Pentz R, et al. HTA im österreichischen Gesundheitswesen. 2020.
3. Zechmeister-Koss I, Stanak M, Wolf S. The status of health economic evaluation within decision making in Austria. Wien Med Wochenschr. 2019;169:271–83. https://doi.org/10.1007/s10354-019-0689-8.
4. Mayer S, Kiss N, Łaszewska A, Simon J. Costing evidence for health care decision-making in Austria: a systematic review. PLoS ONE. 2017;12:e183116. https://doi.org/10.1371/journal.pone.0183116.
5. Feig C, Cheung KL, Hiligsmann M, Evers SMAA, Simon J, Mayer S. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria. Expert Rev Pharmacoeconomics Outcomes Res. 2018;18:223–32.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献